Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
3-[(1R,4S,7S,10S,22S,28S,31S,34S,37R,40S,46S,49S,55S)- 31-benzyl-7-[(2S)-butan-2-yl]-22-(3- carbamimidamidopropyl)-34-[(4- hydroxyphenyl)methyl]-49-(1H-imidazol-5-ylmethyl)- 55-methyl- 3,6,9,15,18,21,24,27,30,33,36,39,45,48,51,54,57,60- octadecaoxo-28,46-bis(propan-2-yl)-62,63-dithia- 2,5,8,14,17,20,23,26,29,32,35,38,44,47,50,53,56,59- octadecaazatetracyclo[35.23.4.0^{10,14}.0^{40,44}]tetrahexacontan-4- yl]propanoic acid
ID: ALA1945676
PubChem CID: 57397978
Max Phase: Preclinical
Molecular Formula: C80H115N23O21S2
Molecular Weight: 1799.07
Molecule Type: Protein
Associated Items: